Addiction clinical trials

Explore recruiting addiction clinical trials.

Recruiting addiction studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Addiction trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase II study of axitinib intensification plus standard of care (SOC) compared to SOC alone after induction with nivolumab plus ipilimumab in mRCC patients without previous complete response (AxIn study).

Italy, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A Four Way Crossover Thorough QT/QTc Study to Evaluate the Electrocardiographic Effects of Therapeutic and Supratherapeutic Doses of Cytisinicline in Healthy Smokers

Portugal

Human Pharmacology (Phase I)- Other EU CTIS Study details

POSITRON - PsilOcybin with pSychologIcal supporT foR cOcaiNe: a randomised controlled pilot feasibility trial of psilocybin with psychological support for cocaine use disorder

Ireland

Therapeutic exploratory (Phase II) EU CTIS Study details

NAlmefene versus placebo in addition to treatment as usual on craving in Behavioural Addictions (NABAb)

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Multicenter, double-blind, randomized, placebo-controlled, dose-response trial with the full-spectrum Cannabis Extract VER-01 in patients with chronic non-specific low back pain

Germany, Czechia, Spain, Poland

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase I, Open-Label Study to Evaluate the Effect of Renal Impairment and Dialysis Treatment on the Pharmacokinetics of a Single 3 mg Cytisinicline Dose

Portugal, Spain

Human Pharmacology (Phase I)- Other EU CTIS Study details

Addiction trials by city

Addiction in Toronto Addiction in Vancouver Addiction in Montreal Addiction in Calgary Addiction in Edmonton Addiction in Ottawa Addiction in Winnipeg Addiction in Quebec City Addiction in Hamilton Addiction in Kitchener Addiction in London Addiction in Halifax Addiction in New York Addiction in Los Angeles Addiction in Chicago Addiction in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease